| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Blood disease–causing and –suppressing transcriptional enhancers: general principles and GATA2 mechanisms
|
Bresnick, Emery H.
|
|
|
3 |
13 |
p. 2045-2056
|
article
|
| 2 |
Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemia
|
Alcantara, Marion
|
|
|
3 |
13 |
p. 1981-1988
|
article
|
| 3 |
COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study
|
Barraclough, Allison
|
|
|
3 |
13 |
p. 2013-2021
|
article
|
| 4 |
Editorial Board
|
|
|
|
3 |
13 |
p. i
|
article
|
| 5 |
First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia
|
Cooley, Sarah
|
|
|
3 |
13 |
p. 1970-1980
|
article
|
| 6 |
Impact of acquired del(17p) in multiple myeloma
|
Lakshman, Arjun
|
|
|
3 |
13 |
p. 1930-1938
|
article
|
| 7 |
Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI
|
Nagler, Arnon
|
|
|
3 |
13 |
p. 1950-1960
|
article
|
| 8 |
Long‐term safety and activity of NY-ESO‐1 SPEAR T cells after autologous stem cell transplant for myeloma
|
Stadtmauer, Edward A.
|
|
|
3 |
13 |
p. 2022-2034
|
article
|
| 9 |
Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphoma
|
Ning, Matthew S.
|
|
|
3 |
13 |
p. 2035-2039
|
article
|
| 10 |
Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition
|
Pianko, Matthew J.
|
|
|
3 |
13 |
p. 2040-2044
|
article
|
| 11 |
Phase 1b study of the MDM2 inhibitor AMG 232 with or without trametinib in relapsed/refractory acute myeloid leukemia
|
Erba, Harry P.
|
|
|
3 |
13 |
p. 1939-1949
|
article
|
| 12 |
Reducing minimal residual disease with blinatumomab prior to HCT for pediatric patients with acute lymphoblastic leukemia
|
Keating, Amy K.
|
|
|
3 |
13 |
p. 1926-1929
|
article
|
| 13 |
Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes
|
Herr, Megan M.
|
|
|
3 |
13 |
p. 1961-1969
|
article
|
| 14 |
STAT3β is a tumor suppressor in acute myeloid leukemia
|
Aigner, Petra
|
|
|
3 |
13 |
p. 1989-2002
|
article
|
| 15 |
Transient and chronic childhood immune thrombocytopenia are distinctly affected by Fc-γ receptor polymorphisms
|
Schmidt, David E.
|
|
|
3 |
13 |
p. 2003-2012
|
article
|
Journal description